Akari Therapeutics PLC (AKTX)
1.525
+0.04
(+3.04%)
USD |
NASDAQ |
May 17, 16:00
1.525
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -8.574M |
| March 31, 2022 | -5.050M |
| December 31, 2021 | -5.004M |
| September 30, 2021 | -1.559M |
| June 30, 2021 | -4.866M |
| March 31, 2021 | -7.418M |
| December 31, 2020 | -4.233M |
| September 30, 2020 | -0.7042M |
| June 30, 2020 | -4.274M |
| March 31, 2020 | -7.740M |
| December 31, 2019 | -3.464M |
| September 30, 2019 | -4.910M |
| June 30, 2019 | -4.772M |
| March 31, 2019 | 0.2289M |
| December 31, 2018 | -4.761M |
| September 30, 2018 | -5.331M |
| June 30, 2018 | -8.284M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.398M |
| December 31, 2017 | -8.517M |
| September 30, 2017 | -9.214M |
| June 30, 2017 | -4.699M |
| March 31, 2017 | -9.168M |
| December 31, 2016 | -6.494M |
| September 30, 2016 | -4.999M |
| June 30, 2016 | -5.691M |
| March 31, 2016 | -7.441M |
| December 31, 2015 | -6.770M |
| September 30, 2015 | 4.491M |
| June 30, 2015 | -0.6975M |
| March 31, 2015 | -1.988M |
| December 31, 2014 | -0.668M |
| September 30, 2014 | 3.567M |
| June 30, 2014 | -2.328M |
| March 31, 2014 | -2.048M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.574M
Minimum
Jun 2022
-0.7042M
Maximum
Sep 2020
-4.813M
Average
-4.866M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| DBV Technologies SA | -34.69M |
| Cellectis SA | 39.72M |
| Adaptimmune Therapeutics PLC | -31.95M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.4825M |